Brookline, MA, United States of America

Athanasia Apostolou

This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignee: Emulate, Inc.. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Athanasia Apostolou. Retrieved from https://idiyas.com/inventor/athanasia-apostolou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Athanasia Apostolou: Innovator in Microfluidic Technology

Introduction

Athanasia Apostolou is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of microfluidic technology, particularly in the modeling of the human gastrointestinal system. With a total of 2 patents, his work is paving the way for advancements in medical research and treatment.

Latest Patents

One of Athanasia's latest patents focuses on the physiology and pathophysiology of the human gut through an innovative intestine-on-chip system. This in vitro microfluidic device mimics the structure and functions of specific areas of the gastrointestinal system in vivo. The multicellular, layered microfluidic intestinal cell culture is derived from patient enteroids-derived cells and includes L cells. This design allows for interactions between L cells and various gastrointestinal epithelial cells, endothelial cells, and immune cells. The system can model inflammatory gastrointestinal autoimmune tissues, such as diabetes, obesity, and intestinal insufficiency. Furthermore, it enables comparisons between different types of gastrointestinal tissues and disease states, facilitating the identification of cellular factors driving disease and drug testing for inflammation reduction.

Career Highlights

Athanasia Apostolou is currently employed at Emulate, Inc., where he continues to develop cutting-edge technologies in the field of microfluidics. His work is instrumental in advancing our understanding of gastrointestinal disorders and improving therapeutic approaches.

Collaborations

Athanasia collaborates with notable colleagues, including Antonio Varone and Magdalena Kasendra, who contribute to the innovative research environment at Emulate, Inc.

Conclusion

Athanasia Apostolou's contributions to microfluidic technology are significant and impactful. His innovative work in developing the intestine-on-chip system is set to revolutionize the study and treatment of gastrointestinal diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…